Geneos Wealth Management Inc. Has $1.17 Million Holdings in Leidos Holdings, Inc. (NYSE:LDOS)

Geneos Wealth Management Inc. lessened its position in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,103 shares of the aerospace company’s stock after selling 112 shares during the period. Geneos Wealth Management Inc.’s holdings in Leidos were worth $1,167,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Rakuten Securities Inc. grew its holdings in shares of Leidos by 1,460.0% during the third quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock worth $25,000 after buying an additional 146 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Leidos during the 3rd quarter worth approximately $29,000. Northwest Investment Counselors LLC bought a new position in shares of Leidos during the 3rd quarter worth approximately $30,000. Berbice Capital Management LLC acquired a new position in Leidos during the fourth quarter worth $29,000. Finally, Kathleen S. Wright Associates Inc. bought a new position in Leidos in the third quarter valued at $46,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on LDOS. UBS Group began coverage on shares of Leidos in a research note on Monday, December 2nd. They set a “neutral” rating and a $182.00 price objective for the company. TD Cowen cut Leidos from a “buy” rating to a “hold” rating and reduced their price target for the company from $200.00 to $165.00 in a research report on Wednesday, January 8th. Citigroup lifted their price objective on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Robert W. Baird boosted their target price on Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Finally, The Goldman Sachs Group cut shares of Leidos from a “buy” rating to a “neutral” rating and lowered their price target for the company from $228.00 to $153.00 in a report on Thursday, December 12th. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $179.07.

Leidos Price Performance

Shares of NYSE:LDOS opened at $148.47 on Tuesday. The firm has a 50 day moving average of $153.95 and a 200-day moving average of $158.39. The stock has a market capitalization of $19.81 billion, a PE ratio of 16.91, a PEG ratio of 1.06 and a beta of 0.66. Leidos Holdings, Inc. has a 12 month low of $108.97 and a 12 month high of $202.90. The company has a current ratio of 1.23, a quick ratio of 1.15 and a debt-to-equity ratio of 0.87.

Leidos (NYSE:LDOS) last posted its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.96 by $0.97. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the company posted $2.03 EPS. On average, equities research analysts predict that Leidos Holdings, Inc. will post 10.03 EPS for the current fiscal year.

Insider Activity

In other Leidos news, Director Noel B. Geer acquired 2,000 shares of Leidos stock in a transaction that occurred on Wednesday, November 20th. The shares were bought at an average price of $161.13 per share, with a total value of $322,260.00. Following the completion of the purchase, the director now directly owns 2,000 shares in the company, valued at $322,260. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now directly owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. This represents a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.96% of the stock is owned by corporate insiders.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.